Jeremy Steele

2.7k total citations
50 papers, 1.7k citations indexed

About

Jeremy Steele is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Neurology. According to data from OpenAlex, Jeremy Steele has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 13 papers in Biotechnology and 12 papers in Neurology. Recurrent topics in Jeremy Steele's work include Occupational and environmental lung diseases (28 papers), Pleural and Pulmonary Diseases (23 papers) and Cancer Research and Treatments (13 papers). Jeremy Steele is often cited by papers focused on Occupational and environmental lung diseases (28 papers), Pleural and Pulmonary Diseases (23 papers) and Cancer Research and Treatments (13 papers). Jeremy Steele collaborates with scholars based in United Kingdom, United States and Italy. Jeremy Steele's co-authors include Robin Rudd, Jonathan Shamash, Marie T. Evans, Michael Sheaff, Astero Klabatsa, Dean A. Fennell, Nicole H. Gower, James Spicer, Marc Tischkowitz and Dean A. Fennell and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Jeremy Steele

49 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Steele United Kingdom 22 1.4k 280 218 186 157 50 1.7k
Martin D. Phillips United States 12 275 0.2× 88 0.3× 349 1.6× 98 0.5× 153 1.0× 16 978
Takahiro Einama Japan 17 297 0.2× 81 0.3× 503 2.3× 72 0.4× 192 1.2× 83 890
William H. Liggett United States 10 411 0.3× 52 0.2× 588 2.7× 45 0.2× 522 3.3× 16 1.2k
Kei Kushitani Japan 19 757 0.6× 35 0.1× 199 0.9× 136 0.7× 159 1.0× 65 959
Anthony Linton Australia 15 482 0.4× 75 0.3× 211 1.0× 37 0.2× 606 3.9× 32 1.2k
Mitsuhito Kaji Japan 17 567 0.4× 30 0.1× 318 1.5× 72 0.4× 496 3.2× 53 1.3k
L-T. Chen Taiwan 17 238 0.2× 165 0.6× 299 1.4× 9 0.0× 252 1.6× 47 906
Hannelore Schmidt Germany 20 396 0.3× 70 0.3× 490 2.2× 12 0.1× 619 3.9× 53 1.2k
Gerard J. Oakley United States 14 246 0.2× 22 0.1× 279 1.3× 44 0.2× 228 1.5× 35 755
Naohiro Asada Japan 13 438 0.3× 19 0.1× 161 0.7× 34 0.2× 127 0.8× 17 726

Countries citing papers authored by Jeremy Steele

Since Specialization
Citations

This map shows the geographic impact of Jeremy Steele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Steele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Steele more than expected).

Fields of papers citing papers by Jeremy Steele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Steele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Steele. The network helps show where Jeremy Steele may publish in the future.

Co-authorship network of co-authors of Jeremy Steele

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Steele. A scholar is included among the top collaborators of Jeremy Steele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Steele. Jeremy Steele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Melissa, Michael D. Allen, Essam Ghazaly, et al.. (2023). A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma. Pharmacological Reports. 75(3). 570–584. 4 indexed citations
2.
Szlosarek, Peter W., Akhila Wimalasingham, Melissa Phillips, et al.. (2021). Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer. Cancer Medicine. 10(19). 6642–6652. 14 indexed citations
3.
Szlosarek, Peter W., Melissa Phillips, Jeremy Steele, et al.. (2020). Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms. JTO Clinical and Research Reports. 1(4). 100093–100093. 23 indexed citations
4.
Lang-Lazdunski, Loı̈c, Sanjay Popat, Mary Claire O’Brien, et al.. (2019). P2.06-05 Multimodality Therapy Using Total Pleurectomy in Malignant Pleural Mesothelioma: Long-Term Outcomes in 150 Consecutive Cases. Journal of Thoracic Oncology. 14(10). S757–S757. 2 indexed citations
5.
Woolhouse, Ian, Lesley Bishop, Liz Darlison, et al.. (2018). British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma. Thorax. 73(Suppl 1). i1–i30. 136 indexed citations
6.
Lang-Lazdunski, Loı̈c, Andrea Billè, Sophie Papa, et al.. (2014). Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience. Journal of Thoracic and Cardiovascular Surgery. 149(2). 558–566. 56 indexed citations
7.
Lang-Lazdunski, Loı̈c, Andrea Billè, Elizabeth Belcher, et al.. (2011). Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 6(10). 1746–1752. 32 indexed citations
8.
Stebbing, Justin, Thomas Powles, Kirsty McPherson, et al.. (2008). The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer. 63(1). 94–97. 108 indexed citations
9.
10.
Fennell, Dean A., Jeremy Steele, Jonathan Shamash, et al.. (2006). Efficacy and safety of first‐ or second‐line irinotecan, cisplatin, and mitomycin in mesothelioma. Cancer. 109(1). 93–99. 37 indexed citations
11.
Steele, Jeremy. (2005). Prognostic Factors for Mesothelioma. Hematology/Oncology Clinics of North America. 19(6). 1041–1052. 26 indexed citations
12.
Steele, Jeremy & Astero Klabatsa. (2005). Chemotherapy options and new advances in malignant pleural mesothelioma. Annals of Oncology. 16(3). 345–351. 51 indexed citations
13.
Klabatsa, Astero, Michael Sheaff, Jeremy Steele, et al.. (2005). Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM). Lung Cancer. 51(1). 53–59. 48 indexed citations
14.
Steele, Jeremy, Astero Klabatsa, Dean A. Fennell, et al.. (2005). Prognostic factors in mesothelioma. Lung Cancer. 49. S49–S52. 48 indexed citations
15.
Fennell, Dean A., Jeremy Steele, Jonathan Shamash, et al.. (2004). Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. Lung Cancer. 47(2). 277–281. 40 indexed citations
16.
Steele, Jeremy. (2002). Prognostic factors in mesothelioma. Seminars in Oncology. 29(1). 36–40. 27 indexed citations
17.
Steele, Jeremy, Jonathan Shamash, Marie T. Evans, et al.. (2001). Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma. Annals of Oncology. 12(4). 497–499. 29 indexed citations
18.
19.
20.
Ashman, Neil, Jeremy Steele, M. Sheaff, Robin Rudd, & James K. Onwubalili. (2000). Membranous nephropathy resolving with treatment of bronchial carcinoid tumor. American Journal of Kidney Diseases. 36(3). e15.1–e15.4. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin D. Phillips Breakdown of academic impact, for papers by Takahiro Einama Breakdown of academic impact, for papers by William H. Liggett Breakdown of academic impact, for papers by Kei Kushitani Breakdown of academic impact, for papers by Anthony Linton Breakdown of academic impact, for papers by Mitsuhito Kaji Breakdown of academic impact, for papers by L-T. Chen Breakdown of academic impact, for papers by Hannelore Schmidt Breakdown of academic impact, for papers by Gerard J. Oakley Breakdown of academic impact, for papers by Naohiro Asada
Rankless by CCL
2026